News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,409 Results
Type
Article (70587)
Company Profile (688)
Press Release (690134)
Multimedia
Podcasts (115)
Webinars (14)
Section
Business (205497)
Career Advice (3476)
Deals (35986)
Drug Delivery (125)
Drug Development (86066)
Employer Resources (181)
FDA (17197)
Job Trends (16294)
News (355081)
Policy (35107)
Tag
Academia (2985)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (95)
Alliances (51551)
ALS (105)
Alzheimer's disease (1502)
Antibody-drug conjugate (ADC) (162)
Approvals (17156)
Artificial intelligence (302)
Autoimmune disease (29)
Automation (17)
Bankruptcy (341)
Best Places to Work (12593)
BIOSECURE Act (22)
Biosimilars (114)
Biotechnology (476)
Bladder cancer (86)
Brain cancer (31)
Breast cancer (315)
Cancer (2500)
Cardiovascular disease (208)
Career advice (2938)
Career pathing (34)
CAR-T (179)
Cell therapy (502)
Cervical cancer (22)
Clinical research (69522)
Collaboration (937)
Company closure (2)
Compensation (584)
Complete response letters (29)
COVID-19 (2792)
CRISPR (50)
C-suite (275)
Cystic fibrosis (110)
Data (2400)
Decentralized trials (2)
Denatured (33)
Depression (55)
Diabetes (296)
Diagnostics (6861)
Digital health (20)
Diversity (6)
Diversity, equity & inclusion (44)
Drug discovery (136)
Drug pricing (129)
Drug shortages (33)
Duchenne muscular dystrophy (105)
Earnings (81621)
Editorial (47)
Employer branding (23)
Employer resources (156)
Events (123651)
Executive appointments (798)
FDA (18642)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (836)
Gene editing (125)
Generative AI (26)
Gene therapy (371)
GLP-1 (840)
Government (4980)
Grass and pollen (6)
Guidances (162)
Healthcare (20769)
Huntington's disease (25)
IgA nephropathy (32)
Immunology and inflammation (154)
Indications (30)
Infectious disease (2951)
Inflammatory bowel disease (159)
Inflation Reduction Act (12)
Influenza (57)
Intellectual property (103)
Interviews (663)
IPO (17185)
IRA (49)
Job creations (4192)
Job search strategy (2419)
Kidney cancer (11)
Labor market (42)
Layoffs (545)
Leadership (24)
Legal (8098)
Liver cancer (82)
Lung cancer (350)
Lymphoma (162)
Machine learning (9)
Management (62)
Manufacturing (372)
MASH (85)
Medical device (14459)
Medtech (14464)
Mergers & acquisitions (19434)
Metabolic disorders (792)
Multiple sclerosis (89)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (34)
Neuroscience (2125)
NextGen: Class of 2025 (7554)
Non-profit (5059)
Now hiring (39)
Obesity (420)
Opinion (274)
Ovarian cancer (84)
Pain (104)
Pancreatic cancer (91)
Parkinson's disease (165)
Partnered (23)
Patents (261)
Patient recruitment (120)
Peanut (51)
People (60184)
Pharmaceutical (140)
Pharmacy benefit managers (24)
Phase I (21665)
Phase II (30386)
Phase III (22858)
Pipeline (1436)
Policy (179)
Postmarket research (2960)
Preclinical (9663)
Press Release (72)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (437)
Real estate (6707)
Recruiting (72)
Regulatory (24381)
Reports (41)
Research institute (2639)
Resumes & cover letters (552)
Rett syndrome (6)
RNA editing (5)
RSV (44)
Schizophrenia (84)
Series A (144)
Series B (98)
Service/supplier (28)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (161)
Sponsored (34)
Startups (3848)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (57)
The Weekly (80)
Vaccines (782)
Venture capitalists (44)
Weight loss (293)
Women's health (35)
Worklife (20)
Date
Today (149)
Last 7 days (1048)
Last 30 days (3443)
Last 365 days (34874)
2025 (12862)
2024 (37722)
2023 (42406)
2022 (53546)
2021 (58404)
2020 (57455)
2019 (51068)
2018 (38696)
2017 (35243)
2016 (35189)
2015 (40868)
2014 (34600)
2013 (32354)
2012 (31564)
2011 (31820)
2010 (30406)
Location
Africa (1049)
Alabama (59)
Alaska (7)
Arizona (213)
Arkansas (14)
Asia (44398)
Australia (8006)
California (6739)
Canada (2104)
China (581)
Colorado (290)
Connecticut (310)
Delaware (170)
Europe (103640)
Florida (988)
Georgia (229)
Hawaii (1)
Idaho (61)
Illinois (628)
India (30)
Indiana (347)
Iowa (12)
Japan (179)
Kansas (112)
Kentucky (28)
Louisiana (15)
Maine (71)
Maryland (996)
Massachusetts (5160)
Michigan (253)
Minnesota (433)
Mississippi (2)
Missouri (93)
Montana (29)
Nebraska (25)
Nevada (70)
New Hampshire (69)
New Jersey (1886)
New Mexico (31)
New York (1896)
North Carolina (1150)
North Dakota (9)
Northern California (2917)
Ohio (226)
Oklahoma (15)
Oregon (48)
Pennsylvania (1477)
Puerto Rico (14)
Rhode Island (36)
South America (1412)
South Carolina (27)
South Dakota (1)
Southern California (2501)
Tennessee (109)
Texas (1005)
United States (25640)
Utah (199)
Virginia (179)
Washington D.C. (72)
Washington State (621)
West Virginia (3)
Wisconsin (73)
761,409 Results for "the new york stem cell foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
Founded in 2007, Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients with rare neurodegenerative diseases
April 24, 2025
·
6 min read
Press Releases
Maryland Stem Cell Research Fund Awards Over $18 Million to Drive Breakthroughs in Regenerative Medicine
May 13, 2025
·
6 min read
Drug Development
First FDA-Approved Phase II Stem Cell Treatment Study Shows Significant Improvements in Progressive MS Patients
The Tisch MS Research Center of New York, the world’s largest MS research center, has announced publication of the results of its FDA-approved Phase II stem cell treatment study in a leading stem cell journal, Stem Cell Research & Therapy.
June 5, 2024
·
4 min read
Press Releases
Joseph Spine Institute Launches Center for Regenerative Spine Medicine, Pioneering Advanced Stem Cell Therapy
April 10, 2025
·
2 min read
Press Releases
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
April 30, 2025
·
1 min read
Press Releases
Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Injected Directly into the Brain for Alzheimer’s Disease in Podium Presentation at the ISCT 2025 Scientific Annual Meeting
May 5, 2025
·
6 min read
Press Releases
Hope Biosciences Research Foundation Authorized to Begin Phase II Clinical Trial in Stem Cell Therapy for Juvenile Idiopathic Arthritis
December 19, 2024
·
2 min read
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Press Releases
PranaX Licenses Exosome Technology to Commercialize Stem Cell Exosomes
March 13, 2025
·
3 min read
Press Releases
Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant
May 5, 2025
·
3 min read
1 of 76,141
Next
